Novel humanized recombinant T cell receptor ligands protect the female brain after experimental stroke.

Transl Stroke Res · 2014 · PMC4121525 · PMID 24838614

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

Although treatment of MCAO using four daily injections of 100 μg RTL1000 produced highly significant reductions in infarct volumes in both females (current study) and males [ 15 ], successful treatment of MCAO with the DRα1 construct given daily for 4 days required a higher dose in females (1 mg) than in males (100 μg).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.